Yahoo! Finance: Top Stories

RBC Capital Lowers PT on Nuvation Bio (NUVB) to $6 But Keeps a Buy Rating

Jun 26, 2025 - 10:18
 0
RBC Capital Lowers PT on Nuvation Bio (NUVB) to $6 But Keeps a Buy Rating
Read More

Tags:

Previous Article

Needham Reiterates a Buy Rating on Autolus Therapeutics (AUTL), Keeps the PT at $10

Next Article

Davidson Reiterates a Buy Rating on Diebold Nixdorf (DBD) With an $80 PT

Related Posts

Treasury Yields Change Little After Strong Consumer Confidence

Treasury Yields Change Little After Strong Consumer Con...

May 27, 2025  0

Buffett Inspires Retail Investors to Bet on Japan Trading Houses

Buffett Inspires Retail Investors to Bet on Japan Tradi...

Jun 5, 2025  0

European, Emerging Market Bonds Benefit as Investors Shift Away from U.S.

European, Emerging Market Bonds Benefit as Investors Sh...

Jun 17, 2025  0